Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ledipasvir × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1 Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 1267 Specimen Handling 900 Carboplatin 824 Magnetic Resonance Spectroscopy 812 Cyclophosphamide 806 Cisplatin 705 Nivolumab 698 Paclitaxel 619 Radiotherapy 608 Gemcitabine 567 Biopsy 544 Bevacizumab 474 Dexamethasone 443 fludarabine 393 Docetaxel 383 venetoclax 380 Oxaliplatin 365 Fluorouracil 363 Capecitabine 358 atezolizumab 350 Rituximab 344 durvalumab 338 Drug Therapy 331 Doxorubicin 319 Radiosurgery 314 Ipilimumab 313 Blood Specimen Collection 311 Standard of Care 309 Pemetrexed 308 Radiation 283

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡